Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Serum vascular endothelial growth factor-D levels in patients with lymphangioleiomyomatosis reflect lymphatic involvement.

Chest - 1 May 2009

Glasgow Connie G, Avila Nilo A, Lin Jing-Ping, Stylianou Mario P, Moss Joel

Abstract excerpt

BACKGROUND: Lymphangioleiomyomatosis (LAM) is a rare multisystem disorder affecting primarily women of child-bearing age, and characterized by cystic lung destruction, tumors of the kidney (angiomyolipomas [AMLs]), and involvement of the axial lymphatics (lymphangioleiomyomas). Patients with LAM...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Area Under Curve
Share to Enzyme-Linked Immunosorbent Assay
Share to Forced Expiratory Volume

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Logistic Models

Share to Lymphatic Vessels

Share to Phenotype

Share to Vital Capacity

Source

Open in PubMed Open full text

Identifiers

PMID: 19420197
DOI: 10.1378/chest.08-1160
PMCID: PMC2818417

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-19420197-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Serum vascular endothelial growth factor-D levels in patients with lymphangioleiomyomatosis reflect lymphatic involvement.PMID 19420197Read ↗

Lymphatic manifestations of lymphangioleiomyomatosis.Semantic proximity Read ↗

Clinical and molecular insights into lymphangioleiomyomatosis.Semantic proximity Read ↗

Pulmonary lymphangioleiomyomatosis.Semantic proximity Read ↗

Lymphangioleiomyomatosis: new concepts in pathogenesis, diagnosis, and treatment.Semantic proximity Read ↗

Lymphangioleiomyomatosis: pathogenesis, clinical features, diagnosis, and management.Semantic proximity Read ↗

The Role of Moesin in Diagnosing and Assessing Severity of LymphangioleiomyomatosisSemantic proximity Read ↗

Lymphangioleiomyomatosis: A review.Semantic proximity Read ↗

LymphangioleiomyomatosisSemantic proximity Read ↗

Lymphangioleiomyomatosis (LAM): molecular insights lead to targeted therapies.Semantic proximity Read ↗

New insights in lymphangioleiomyomatosis and pulmonary Langerhans cell histiocytosis.Semantic proximity Read ↗

Lymphangioleiomyomatosis: where endocrinology, immunology and tumor biology meetSemantic proximity Read ↗

The vitamin D binding protein axis modifies disease severity in lymphangioleiomyomatosis.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.